Access the full text.
Sign up today, get DeepDyve free for 14 days.
In a preliminary uncontrolled trial, an oral vitamin B12 formulation (cyanocobalamin aminolate, trade name CobamaxTM) containing 600 μg vitamin B12 per day was administered to a small cohort of HIV + individuals, most of whom had been previously diagnosed with AIDS. Responses to a set of self-rated questionnaires suggested that the vitamin formulation was remarkably effective in moderating or resolving a broad range of AIDS-related symptoms, including fatigue, depression, night sweats, oral thrush, fevers, diminished appetite, gastrointestinal distress, impaired memory and concentration, pain in general and peripheral neuropathy. These preliminary results remain to be confirmed by additional studies.
Journal of Advancement in Medicine – Springer Journals
Published: Sep 30, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.